Strengthens the depressing effect on the central nervous system for general anesthesia, hypnotics and sedatives, narcotic analgesics and tranquilizers.
Anticoagulants (ardeparin sodium, dalteparin sodium, sodium danaparoid, sodium enoxaparin, heparin, warfarin) increase the risk of bleeding.
When treating the site of injection of a local anesthetic with disinfectant solutions containing heavy metals, the risk of developing a local reaction in the form of tenderness and swelling increases.
Use with monoamine oxidase (MAO) inhibitors (furazolidone, procarbazine, selegiline) increases the risk of developing hypotension.
Strengthen and prolong the action of muscle relaxants.
In the appointment of procaine, together with narcotic analgesics, an additive effect is noted that is used in spinal and epidural anesthesia, and respiratory depression is increased.
Vasoconstrictors (epinephrine, methoxamine, phenylephrine) extend the local anesthetic effect.
Procaine reduces the anti-asthma effect of drugs, especially when used in high doses, which requires an additional correction for the treatment of myasthenia gravis.
Cholinesterase inhibitors (antimiasthenic drugs, cyclophosphamide, thiotepa) reduce the metabolism of procaine.
Metabolite procaine (paraaminobenzoic acid) is a sulfonamide antagonist.